Short answer
Semaglutide is a long-acting peptide agonist of the GLP-1 receptor. It was engineered with a fatty acid modification that extends its activity, and it is one of the most studied compounds in incretin and metabolic signaling research. PEPMAKE sells it as a lyophilized research powder.
What is semaglutide?
Semaglutide is a synthetic peptide based on the natural hormone GLP-1 (glucagon-like peptide-1). GLP-1 is released from the gut and activates receptors involved in insulin secretion, appetite signaling and gastric emptying [1].
Unlike the natural hormone, semaglutide is designed to resist rapid breakdown. A C18 fatty acid chain binds to albumin in the blood, which slows clearance and gives the peptide a much longer duration of action [1].
Why it matters in research
GLP-1 receptor agonists are one of the most active areas in metabolic research. Reviews in Nature Metabolism and Nature Reviews Endocrinology describe the GLP-1 pathway as central to understanding incretin biology and the development of receptor-targeting peptides [1][2].
Researchers use semaglutide as:
Key facts at a glance
| Property | Detail |
|---|---|
| Type | GLP-1 receptor agonist peptide |
| Design feature | C18 fatty acid for extended activity |
| Research themes | Incretin signaling, metabolic pathways |
| Typical form | Lyophilized powder |
| Purity expectation | 99%+ by HPLC |
Buying checklist
Browse Semaglutide product options or the GLP-1 research category.
FAQ
What is semaglutide?
A long-acting GLP-1 receptor agonist peptide studied in metabolic research.
Why is it long-acting?
A fatty acid chain binds albumin and slows clearance.
How is it studied?
Receptor assays, cell signaling studies, animal models and clinical literature analysis.
Is it for human use?
No, laboratory research use only.